Press Releases from Aquigen Biosciences (22 total)
Precision Standards for Oncology Research: Exploring Abemaciclib Impurity 1 and …
In the ever-evolving field of targeted cancer therapy, Abemaciclib has emerged as a pivotal agent in the treatment of hormone receptor-positive (HR+), HER2-negative advanced or…
N-Nitrosomorpholine: Addressing Pharmaceutical Safety Challenges with Aquigen Bi …
N-Nitrosomorpholine, a compound belonging to the nitrosamine family, has garnered significant attention in the pharmaceutical and healthcare industries due to its potential carcinogenic risks. This…
(S)-N-Nitroso Anabasine: Understanding the Risks, Regulatory Challenges, and How …
(S)-N-Nitroso Anabasine, a nitrosamine impurity, has raised significant safety concerns within the pharmaceutical industry. Recognized as a probable human carcinogen, this impurity has become a…
N-Nitroso Acetylcysteine: A Critical Concern in Pharmaceuticals - Exploring Haza …
N-Nitroso Acetylcysteine has emerged as a critical topic of concern in the pharmaceutical industry. As a member of the nitrosamine family, it is a potential…
N-Nitroso-D-Proline: A Growing Concern for Pharmaceutical Safety - Explore How A …
N-Nitroso-D-Proline, a chemical impurity belonging to the nitrosamine family, has emerged as a significant concern for pharmaceutical manufacturers worldwide. Its presence in drugs, even at…
N-Nitrosomorpholine: Addressing Pharmaceutical Safety Challenges with Aquigen Bi …
N-Nitrosomorpholine, a compound belonging to the nitrosamine family, has garnered significant attention in the pharmaceutical and healthcare industries due to its potential carcinogenic risks. This…
N-Nitroso Phenylephrine: Ensuring Pharmaceutical Safety with Advanced Solutions …
N-Nitroso Phenylephrine, a nitrosamine impurity, has emerged as a significant safety concern in the pharmaceutical industry. As regulatory authorities worldwide heighten their scrutiny of nitrosamine…
2-Nitroso-1-Pentylpiperazine Impurities in Pharmaceutical Manufacturing: Explori …
2-Nitroso-1-Pentylpiperazine has recently emerged as a significant area of concern within the pharmaceutical industry. As a potentially carcinogenic impurity, this nitroso compound poses substantial risks…
(S)-3-(Boc-amino)piperidine Nitroso Impurity: A Global Concern For Safe Pharmace …
(S)-3-(Boc-amino)piperidine nitroso impurity is an emerging concern for pharmaceutical manufacturers and quality control teams around the globe. As a potentially harmful byproduct, it can be…
Indomethacin Nitroso Impurity 1: Ensuring Safe NSAID Use with Advanced Detection …
Indomethacin Nitroso Impurity 1 is a critical impurity associated with Indomethacin, a widely used non-steroidal anti-inflammatory drug (NSAID) prescribed for various inflammatory conditions such as…
Ceritinib Nitroso Impurity 1: Enhancing Cancer Therapy Safety with Aquigen Bio S …
Ceritinib Nitroso Impurity 1 is an impurity associated with ceritinib, a targeted therapy medication primarily used in the treatment of non-small cell lung cancer (NSCLC).…
Dabigatran Nitroso Impurity 1: Ensuring Quality, Safety, and Regulatory Complian …
Dabigatran Nitroso Impurity 1 has become essential in pharmaceutical quality control, particularly for medications used in anticoagulation therapy. As a type of nitrosamine, this impurity…
Enalaprilat Nitroso Impurity: Comprehensive Testing, Regulatory Compliance, and …
Enalaprilat Nitroso Impurity has emerged as a significant topic within pharmaceutical research and development, drawing attention to the crucial need for impurity standards and quality…
Elagolix Nitroso Impurity: An Essential Quality Standard by Aquigen BioSciences …
Elagolix Nitroso Impurity signifies an important advancement in the pharmaceutical sector, aimed at laboratories and pharmaceutical companies focused on ensuring the quality and safety of…
Solifenacin EP Impurity A Nitroso Impurity: Navigating Compliance Risks, Regulat …
Solifenacin EP Impurity A Nitroso Impurity has surfaced as a pressing concern in the pharmaceutical industry, raising significant alarms among manufacturers and regulatory bodies. This…
Losartan Nitroso Impurity: Addressing Compliance Risks, Regulatory Challenges, a …
Losartan Nitroso Impurity has emerged as a significant concern in the pharmaceutical industry as it faces mounting scrutiny regarding nitroso impurities. This issue has raised…
Buspirone Nitroso Impurity 1: A Growing Concern for Patient Safety, Health Risks …
Buspirone Nitroso Impurity 1 has recently emerged as a critical concern within the pharmaceutical landscape, particularly about mental health medications. As a widely prescribed anxiolytic,…
Bumetanide Nitroso Impurity: Mitigating Compliance Risks and Integrating Innovat …
Bumetanide Nitroso Impurity has emerged as a significant concern in the pharmaceutical industry, particularly for companies involved in the development and manufacturing of medications used…
Mitigating N-Nitroso Bis(2-chloroethyl)amine (NBCEA) Impurities in Pharmaceutica …
N-Nitroso Bis(2-chloroethyl)amine, also known as NBCEA, is a challenging impurity that pharmaceutical companies must manage when developing high-risk drug products. This potentially carcinogenic compound is…
Crizotinib Nitroso Impurity: Understanding the Potential Risks, Safety Concerns, …
Crizotinib, a life-saving drug widely used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC), is at the centre of…
Sumatriptan Nitroso Impurity: Navigating Compliance Challenges and Implementing …
Sumatriptan Nitroso Impurity has become a pressing concern in the pharmaceutical industry, as companies grapple with significant compliance challenges related to these potentially harmful contaminants.…
N-Nitrosodicyclohexylamine Contamination: Challenges for Pharmaceutical Manufact …
The pharmaceutical industry is facing a new safety challenge with the detection of N-Nitrosodicyclohexylamine (NDCHA), a nitrosamine impurity found in various medications. The emergence of…
Go To Page:
